Graves' Disease Treatment
Join us to explore a new treatment option for adults with Graves' disease who are experiencing hyperthyroidism.
Study site: NeoClinical Research
- Graves' disease
Recruiting
Male/Female
18 - 70 years of age
TBD
- About the Study
- We are looking for adult participants with Graves' disease who are actively dealing with hyperthyroidism to evaluate a new treatment's effectiveness and safety.
- What does the study involve?
- The treatment will be given just under the skin using an autoinjector.
What to expect
- Placebo
- You may receive a placebo (a look-alike with no active medicine).
- Which treatment you get
- Chosen at random. Neither you nor the study team will know which treatment you get.
- Who can participate?
- We're looking for adults with confirmed Graves' disease and active hyperthyroidism. You should not have had hyperthyroidism from other causes or certain recent treatments. Think you might qualify? Apply to find out!
Where is the study taking place?
Palmetto Medical Plaza
Study details
- Sponsor
- Biohaven Therapeutics Ltd.
- Phase
- Phase 3: confirming it works in a large group, often against current treatment
- Dates
- June 2026 to February 2028 (expected)
- Size
- 300 participants across all sites
- Healthy volunteers
- Only people with the condition
Study details are from ClinicalTrials.gov. The rest of this page is written by the study site for patients and may summarize or reword the registry record, which is the official text. A study listed on ClinicalTrials.gov has not necessarily been reviewed or approved by the U.S. government.
One moment…
About NeoClinical Research
NeoClinical Research is a leading, multi-therapeutic clinical research center based in South Florida that bridges the gap between leading pharmaceutical companies and diverse patient populations.